Showing results (71-80 of 103) with videos related to
Sort By:
Pageof 11
The Journal of Clinical Endocrinology and Metabolism|April 6, 2016
Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid CancerJill J Bastman, Hilary S Serracino, Yuwen Zhu, et al.Medrxiv : the Preprint Server for Health Sciences|June 5, 2026
Telomere maintaining germline and somatic variants in thyroid cancer and melanomaSandya Liyanarachchi, Pamela L Brock, Wei Li, et al.Thyroid : Official Journal of the American Thyroid Association|December 17, 2021
What's in a Name? A Cost-Effectiveness Analysis of the Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features' Nomenclature RevisionVikas Mehta, Ankita Naraparaju, David Liao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2020
Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor-Positive Breast CancersReema S Wahdan-Alaswad, Susan M Edgerton, Hiba Salem, et al.Nature Communications|July 10, 2026
Genetic drivers of etiologic heterogeneity in thyroid cancerYon Ho Jee, Nikita Pozdeyev, Christopher R Gignoux, et al.The Journal of Clinical Endocrinology and Metabolism|September 8, 2023
Thyroid Cancer Polygenic Risk Score Improves Classification of Thyroid Nodules as Benign or MalignantNikita Pozdeyev, Manjiri Dighe, Martin Barrio, et al.The Lancet. Diabetes & Endocrinology|May 3, 2025
Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statementSophie Leboulleux, Laura Boucai, Naifa Busaidy, et al.Thyroid : Official Journal of the American Thyroid Association|October 29, 2009
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer, David S Cooper, Gerard M Doherty, et al.The Journal of Clinical Endocrinology and Metabolism|April 10, 2014
mTOR Inhibition promotes TTF1-dependent redifferentiation and restores iodine uptake in thyroid carcinoma cell linesTheo S Plantinga, Bas Heinhuis, Danny Gerrits, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2006
Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawalHeribert Hänscheid, Michael Lassmann, Markus Luster, et al.Pageof 11